Clinical Webinar – From Theory to Practice: Maximizing Aminoglycoside Efficacy with the AUC-guided TDM

Register for the virtual event: From Theory to Practice: Maximizing Aminoglycoside Efficacy with the AUC-guided TDM

US: Tuesday, September 19 at 8PM ET

AU: Wednesday, September 20 at 10AM AEST

• Discover best practices for dosing and monitoring gentamycin, tobramycin and amikacin based on current and anticipated guidelines
• Learn more about the bedside application of tobramycin through exciting new study results
• Explore peak/trough vs. AUC dosing and understand why the Children’s Hospital at Westmead opted for precision dosing software

Tony Lai, Senior Pharmacist, Antimicrobial Stewardship/Infectious Diseases, at The Children’s Hospital at Westmead, Australia, has experience in an extensive range of Sydney hospitals spanning over 15 years in pediatrics and adults. His expert advisory editor roles include the Society of Hospital Pharmacy Australia (SHPA) Injectables Drugs Handbook, Australasian Neonatal Medicines Formulary (ANMF) and the upcoming Therapeutic Guidelines: Antibiotic. His research interest is dose optimization of antimicrobials and is currently a PhD candidate investigating liposomal amphotericin B therapeutic drug monitoring in children.

Sharmeen Roy, PharmD, BCPS, Chief Strategy and Science Officer, DoseMe, has over 20-years experience that spans pediatric clinical pharmacy, clinical research, and pharmacogenomics. She is passionate about leveraging technology to amplify the impact of the pharmacist. She received her Doctor of Pharmacy degree from the University of Illinois at Chicago and completed a Pediatric Specialty Pharmacotherapy Residency at Texas Children’s Hospital.